Market Synopsis of U.S. Personalized Medicine Market:
An expert on premium research reports, Market Research
Future has added a report titled " U.S. Personalized
Medicine Market Research Report - Forecast To 2023" to its offering. The
report provides an in-depth analysis of regional data and an accurate
projection of the market size and share of the Top 10 market players across the
globe.
Market Scenario:
The Personalized Medicine Market is the most recent trend in the
multibillion–dollar molecular diagnostics industry. Pharmaceutical and
biotechnology companies are increasingly turning to personalized medicine in
order to improve the drug development process and also to speed up the approval
or sanction of new drugs.
Get Sample Copy @
According to the industry consensus, personalized medicine will not only
form an integral part of typical medicine in the next few years, it is also
anticipated to reform the development, testing, marketing and prescription of
drugs during the next decade. The big pharmaceutical companies eventually will
change their tried and tested epic business model to more–targeted and
effective healthcare solutions. U.S personalized medicine market is expected to
grow at the CAGR of 7.5% during the forecasted period.
Key players of U.S. Personalized Medicine Market:
·
Laboratory Corporation of America
·
Quest Diagnostics
·
Abbott
·
Becton Dickinson & Co.
·
Siemens Healthcare Diagnostics Inc.
·
GE Healthcare
·
Pfizer Inc.
·
Sanofi
·
CardioDx Inc.
·
Asuragen Inc.
·
Bristol-Myers Squibb
Segments:
The U.S. Personalized Medicine Market is segmented on the basis of
product, application and end users. Based on the product, the market has been
segmented as diagnostic, therapeutics, medical care and
nutrition and wellness and others. Based on application,
the market has been segmented into diagnosis and intervention, drug development
and usage, cancer genomics and others. Further
on the basis of end users the market has been segmented as hospitals,
molecular diagnostic laboratories and testing centers, academic institutes, bio
and health informatics companies and others.
Regional Analysis
U.S. accounts for the maximum market share of the personalized medicine
market and the market is expected to increase continuously in coming years.
This can be attributed to increasing pool of cancer patients along with high
healthcare per capita expenditure. Advancing technologies within the liquid
biopsy or cancer market is also driving the market and will see strategic
growth over the next five years. The two segments of the liquid biopsy market
are tumor cell enrichment products and tumor cell detection technologies which
are expected to command the maximum market share.
Browse Complete 110 Pages Premium Research Report
Enabled with 77 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/personalized-medicine-market-2937
Detailed
Table of Contents:
Table Of Contents
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
List Of Tables and Figures
List Of Tables
Table 1 U.S. Personalised Medicine Market, By
Product, 2017-2023 (Usd Million)
Table 2 U.S. Personalised Medicine Market, By
Application, 2017-2023 (Usd Million)
Table 3 U.S. Personalised Medicine Marketby
End Users 2017-2023 (Usd Million)
Table 4 U.S. Personalised Medicine Market, By
Region 2017-2023 (Usd Million)
List Of Figures
Figure 1 Research Process
Figure 2 Porters Five Forces Model
Figure 3 U.S. Personalised Medicine Market, By
Product
Figure 4 U.S. Personalised Medicine Market, By
Application
Figure 5 U.S. Personalised Medicine Market, By
End Users
Figure 6 U.S. Personalised Medicine Market, By
Region
Figure 7 U.S. Personalised Medicine Market:
Company Share Analysis, 2016 (%)
...Continued
About US:
Market Research Future (MRFR), enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment